CLINICAL-DIAGNOSTIC ASSESSMENT OF PATIENTS WITH UTERINE CERVICAL CANCER

Kamyshov S. V.*

ABSTRACT

The aim of the study was to assess the clinical and diagnostic characteristics of patients with cervical cancer, who were recommended to accompany immunopharmacotherapy. Consequently, in the majority - 44.4% of patients were diagnosed with the IIIB stage of the disease. In most cases, 52.2% of the patients examined had a tumor volume ranging from 10 to 15 cm.[3] The initial tumor in most patients ie. in 61.2% it was not possible to determine with the help of clinical and instrumental methods. In the majority of 44.0% of patients with cervical cancer, the tumor spread to the upper third of the vagina. When appointing EIPHT methods, patients with cervical cancer were treated with anamnestic data, the presence of specific antitumor or nontraditional types of treatment before admission to hospital, as well as the histological type of tumor, the macroscopic form of growth and the extent of its prevalence.

Keywords: Cervical cancer, clinical and morphological features, degree of differentiation.